Dr Ravinder Datt Bhanot, MD | |
1015 S Washington Ave Ste E, Saginaw, MI 48601-2556 | |
(989) 907-7636 | |
Not Available |
Full Name | Dr Ravinder Datt Bhanot |
---|---|
Gender | Male |
Speciality | Pulmonary Disease |
Experience | 22 Years |
Location | 1015 S Washington Ave Ste E, Saginaw, Michigan |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1558649202 | NPI | - | NPPES |
4301098823 | Other | MI | STATE MEDICAL LICENCE - MICHIGAN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RP1001X | Internal Medicine - Pulmonary Disease | 4301098823 (Michigan) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Ascension St Mary's Hospital | Saginaw, MI | Hospital |
Saint Mary's Standish Community Hospital | Standish, MI | Hospital |
Tawas St Joseph Hospital | Tawas city, MI | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Ascension St. Mary's Hospital | 6305737156 | 87 |
News Archive
The African Union (A.U.) "held a rare fundraiser in Ethiopia Thursday in a bid to plug a $1.1 billion shortfall in aid for millions facing starvation in the Horn of Africa's worst drought in decades," Agence France-Presse reports.
Hologic, Inc., a leading women's healthcare company, today announced that final data analysis from the first large-scale independent evaluation of clinical performance of Cervista HPV HR compared to Hybrid Capture 2, were presented in Montreal, Canada, at the 26th International Papillomavirus Conference. Cervista HPV HR is a diagnostic test for the detection of 14 high-risk human papillomavirus types.
Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today announced the initiation of a Phase 1 trial of CAL-101, the Company's oral, PI3K delta inhibitor, in combination with standard of care agents Rituxan® (rituximab) and/or Treanda® (bendamustine) in patients with relapsed or refractory indolent non-Hodgkin's lymphoma or chronic lymphocytic leukemia.
The prestigious medical journal, Mayo Clinic Proceedings, recently published new insulin delivery recommendations for health care professionals caring for insulin-using patients, including the results from the largest injection technique survey ever performed for people with diabetes.
› Verified 1 days ago
Entity Name | Ascension St. Mary's Hospital |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1326658154 PECOS PAC ID: 6305737156 Enrollment ID: O20040326000404 |
News Archive
The African Union (A.U.) "held a rare fundraiser in Ethiopia Thursday in a bid to plug a $1.1 billion shortfall in aid for millions facing starvation in the Horn of Africa's worst drought in decades," Agence France-Presse reports.
Hologic, Inc., a leading women's healthcare company, today announced that final data analysis from the first large-scale independent evaluation of clinical performance of Cervista HPV HR compared to Hybrid Capture 2, were presented in Montreal, Canada, at the 26th International Papillomavirus Conference. Cervista HPV HR is a diagnostic test for the detection of 14 high-risk human papillomavirus types.
Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today announced the initiation of a Phase 1 trial of CAL-101, the Company's oral, PI3K delta inhibitor, in combination with standard of care agents Rituxan® (rituximab) and/or Treanda® (bendamustine) in patients with relapsed or refractory indolent non-Hodgkin's lymphoma or chronic lymphocytic leukemia.
The prestigious medical journal, Mayo Clinic Proceedings, recently published new insulin delivery recommendations for health care professionals caring for insulin-using patients, including the results from the largest injection technique survey ever performed for people with diabetes.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Ravinder Datt Bhanot, MD 23950 Noble Dr, Farmington Hills, MI 48336-2746 Ph: (313) 695-5662 | Dr Ravinder Datt Bhanot, MD 1015 S Washington Ave Ste E, Saginaw, MI 48601-2556 Ph: (989) 907-7636 |
News Archive
The African Union (A.U.) "held a rare fundraiser in Ethiopia Thursday in a bid to plug a $1.1 billion shortfall in aid for millions facing starvation in the Horn of Africa's worst drought in decades," Agence France-Presse reports.
Hologic, Inc., a leading women's healthcare company, today announced that final data analysis from the first large-scale independent evaluation of clinical performance of Cervista HPV HR compared to Hybrid Capture 2, were presented in Montreal, Canada, at the 26th International Papillomavirus Conference. Cervista HPV HR is a diagnostic test for the detection of 14 high-risk human papillomavirus types.
Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today announced the initiation of a Phase 1 trial of CAL-101, the Company's oral, PI3K delta inhibitor, in combination with standard of care agents Rituxan® (rituximab) and/or Treanda® (bendamustine) in patients with relapsed or refractory indolent non-Hodgkin's lymphoma or chronic lymphocytic leukemia.
The prestigious medical journal, Mayo Clinic Proceedings, recently published new insulin delivery recommendations for health care professionals caring for insulin-using patients, including the results from the largest injection technique survey ever performed for people with diabetes.
› Verified 1 days ago
Jerry Xavier, Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1000 Houghton Ave, 1100 Internal Medicine, Saginaw, MI 48602 Phone: 989-583-5826 | |
Ray Peter Mangulabnan, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 3170 Hallmark Ct, Saginaw, MI 48603 Phone: 989-790-1275 Fax: 989-249-4199 | |
Shafia Beg, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1000 Houghton Ave, Saginaw, MI 48602 Phone: 989-583-6800 | |
Dr. Natasa Petreska, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1000 Houghton Ave, Saginaw, MI 48602 Phone: 989-746-7500 | |
Dr. Manoj Sharma, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 4884 Berl Dr, Saginaw, MI 48604 Phone: 989-497-9395 Fax: 989-497-9599 | |
Minoo Khetarpal, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1320 N Michigan Ave, Suite 4, Saginaw, MI 48602 Phone: 989-755-5500 Fax: 989-755-7860 | |
Christine I Rohr, D.O. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1000 Houghton Ave, Saginaw, MI 48602 Phone: 989-583-6800 Fax: 989-583-6915 |